TROUBLE VIEWING? Click Here to view the Promo card on the web
SIGN-UP NOW! Click to become a Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More
top banner

C. diff. Spores and More

Tuesday at 10 AM Pacific

May 26th 2015: Dr. Nicholas Kartsonis discusses the many contributions of Merck and ongoing research addressing CDI

Join us to hear from Merck's Dr. Nick Kartsonis, and the history in addressing infectious disease and antimicrobial resistance. Dr. Nick Kartsonis will also be discussing the future in the area of C. diff. and some of the company's current treatments, including DIFICID and their ongoing research addressing CDI.

Download PDF DOWNLOAD PDF

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guest

Guest Image

Dr. Nicholas Kartsonis

Dr. Nicholas Kartsonis , Associate Vice President of Clinical Research for Infectious Diseases for Merck Research Laboratories (MRL) and Section Head within MRL
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
Facebook Twitter Linkedin Social Media
presspass-banner